NCT01723735 - Effect of Alirocumab (SAR236553/REGN727) Administered on Top of Ezetimibe or Fenofibrate on Lipid Profiles in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions

Hypercholesterolemia

Interventions

DRUG

Alirocumab

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous"

DRUG

Ezetimibe

"Pharmaceutical form: overencapsulated tablet~Route of administration: oral"

DRUG

Ezetimibe Placebo

"Pharmaceutical form: capsule~Route of administration: oral"

DRUG

Fenofibrate

"Pharmaceutical form: tablet~Route of administration: oral"

Trial Locations (2)

Investigational Site Number 250001, Rennes

Investigational Site Number 250002, Rueil-Malmaison